Why the effectiveness of ETSs on green innovation differs? The perspective from price stabilization mechanisms
Peer-Reviewed Publication
Updates every hour. Last Updated: 8-Jan-2026 19:11 ET (9-Jan-2026 00:11 GMT/UTC)
Price stabilization mechanisms (PSMs), one of a set of key policy elements aiming at supporting increasing and stable carbon prices, may affect the performance of emissions trading systems (ETS) in terms of green innovation. By using the case of China’s regional carbon market pilots and data of listed firms, the research team found that pilots adopting both price-based and quantity-based PSMs significantly induced green innovation activities in covered firms, while a single type does not guarantee the effect. PSMs help to do so by lifting carbon prices and reducing firms’ perceived uncertainties. The above effects would be enhanced in firms with lower asset reversibility, lower ability of cost passthrough, higher ability of innovation, and state-owned enterprises.
The enforcement of the historic United States law to combat international corruption was suspended on 10 February 2025 through a presidential executive order. On the same day, companies under investigation or sanctioned for corruption increased their market capitalisation by an average of USD 160 million. A signal that could also lead other countries to scale back their efforts to fight international corruption
Colloidal quantum dot (QD) light-emitting diodes have great potential in display applications. However, their commercialization remains a challenge due to the difficulty in achieving high-resolution patterning of QDs without degrading their optical properties. To address this, researchers have developed a nondestructive method for ultrahigh-resolution QD patterning. By blending QDs with a photocrosslinkable polymer, the approach preserves their optical properties and boosts efficiency and lifetime, paving the way for development of next-generation display technologies.
The 2024 report on China’s gastroenterology and digestive endoscopy, based on national databases, highlights increased early cancer detection, optimized care for priority diseases, and enhanced endoscopy quality, with mixed cost trends for inflammatory bowel disease.